最新更新 :
03/02/2026

搜索 搜索

专题 Cyclophosphamide 注射液抗癌藥物 Cyclophosphamide (英国, 美国, 沙特阿拉伯, 新西蘭)
ATC : L01AA01
专题 Cyclophosphamide 口服剂抗癌藥物 ATC : L01AA01
专题 Cyclophosphamide 胶囊抗癌藥物 ATC : L01AA01
引用文献 40 Pharm Sci Communications Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
引用文献 50 Am J Health-Syst Pharm Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
引用文献 170 Am J Hosp Pharm Effect of briefly heating cyclophosphamide solutions.
引用文献 172 J Parenter Sci Technol Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
引用文献 1728 Pharmazie Stability of cyclophosphamide containing infusions.
引用文献 1833 Ann Pharmacotherapy Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
引用文献 2000 J Pharm Biomed Anal Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
引用文献 2016 Am J Health-Syst Pharm Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
引用文献 3096 Ann Pharmacotherapy Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
引用文献 4865 Dr REDDY laboratoire Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.
引用文献 4989 Dr REDDY Extended dilution stability study report of cyclophosphamide concentrate for solution for infusion at room temperature and refrigerated condition ( 2-8°C) - Personal communication - July 2025

  Mentions Légales